GENDER- AND AGE-SPECIFIC CLINICO-EPIDEMIOLOGICAL PROFILE OF LUNG CANCERS IN CENTRAL INDIA
Main Article Content
Keywords
Abstract
Lung cancer exhibits diverse patterns of incidence, prevalence, and clinical attributes, influenced by geographical and demographic factors. This study delves into the gender- and age-specific clinico-epidemiological profile of lung cancers in Central India. Specifically, it analyzes gender-segregated incidence rates, provides insight into the age groups most affected by this malignancy, and presents age-wise distribution of lung cancer cases. By synthesizing existing research, this review facilitates a nuanced understanding of lung cancer trends in the region and offers guidance for future research and healthcare initiatives.
References
1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization; 2008.
2. Viswanathan R, Sen Gupta, Iyer PV. Incidence of primary lung cancer in India. Thorax. 1962; 17:73–6.
3. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Unchanging clinico-epidemiological profile of lung cancer in North India over three decades. Cancer Epidemiol. 2010; 34:101–4.
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394– 424.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127:2893–917.
6. Mohan A, Garg A, Gupta A, et al. Clinical profile of lung cancer in North India: a 10-year analysis of 1862 patients from a tertiary care center. Lung India. 2020; 37:190–197.
7. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Unchanging clinico-epidemiological profile of lung cancer in North India over three decades. Cancer Epidemiol. 2010; 34:101–104.
8. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Quantified smoking status and non-small cell lung cancer stage at presentation: analysis of a North Indian cohort and a systematic review of literature. J Thorac Dis. 2012; 4:474–484.
9. Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: A meta-analysis. Lung Cancer. 2000; 27:3–18.
10. Kaur H, Sehgal IS, Bal A, et al. Evolving epidemiology of lung cancer in India: reducing non-small cell lung cancer not otherwise specified and quantifying tobacco smoke exposure are the key. Indian J Cancer. 2017; 54:285–290.
11. Singh N. Lung cancer in India: the rewards of REWERDS (Real World Evidence from Retrospective Data analysis). Curr Probl Cancer. 2020; 44:100591.
12. Malik PS, Sharma MC, Mohanti BK, Shukla NK, Deo S, Mohan A, et al. Clinico-pathological profile of lung cancer at AIIMS: A changing paradigm in India. Asian Pac J Cancer Prev. 2013; 14:489–94.
13. Apurva A, Tandon SP, Shetmahajan M, Jiwnani SS, Karimundackal G, Pramesh CS. Surgery for lung cancer— the Indian scenario. Indian J Thorac Cardiovasc Surg. 2018; 34:47–53.
14. Jindal SK, Behera D. Clinical spectrum of primary lung cancer – Review of Chandigarh experience of 10 years. Lung India. 1990; 8:94–8.
2. Viswanathan R, Sen Gupta, Iyer PV. Incidence of primary lung cancer in India. Thorax. 1962; 17:73–6.
3. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Unchanging clinico-epidemiological profile of lung cancer in North India over three decades. Cancer Epidemiol. 2010; 34:101–4.
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394– 424.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127:2893–917.
6. Mohan A, Garg A, Gupta A, et al. Clinical profile of lung cancer in North India: a 10-year analysis of 1862 patients from a tertiary care center. Lung India. 2020; 37:190–197.
7. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Unchanging clinico-epidemiological profile of lung cancer in North India over three decades. Cancer Epidemiol. 2010; 34:101–104.
8. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Quantified smoking status and non-small cell lung cancer stage at presentation: analysis of a North Indian cohort and a systematic review of literature. J Thorac Dis. 2012; 4:474–484.
9. Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: A meta-analysis. Lung Cancer. 2000; 27:3–18.
10. Kaur H, Sehgal IS, Bal A, et al. Evolving epidemiology of lung cancer in India: reducing non-small cell lung cancer not otherwise specified and quantifying tobacco smoke exposure are the key. Indian J Cancer. 2017; 54:285–290.
11. Singh N. Lung cancer in India: the rewards of REWERDS (Real World Evidence from Retrospective Data analysis). Curr Probl Cancer. 2020; 44:100591.
12. Malik PS, Sharma MC, Mohanti BK, Shukla NK, Deo S, Mohan A, et al. Clinico-pathological profile of lung cancer at AIIMS: A changing paradigm in India. Asian Pac J Cancer Prev. 2013; 14:489–94.
13. Apurva A, Tandon SP, Shetmahajan M, Jiwnani SS, Karimundackal G, Pramesh CS. Surgery for lung cancer— the Indian scenario. Indian J Thorac Cardiovasc Surg. 2018; 34:47–53.
14. Jindal SK, Behera D. Clinical spectrum of primary lung cancer – Review of Chandigarh experience of 10 years. Lung India. 1990; 8:94–8.